National Mycobacteriology Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic.
Enteric Virus and Measles Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic.
PLoS One. 2019 Mar 20;14(3):e0213735. doi: 10.1371/journal.pone.0213735. eCollection 2019.
Measles remains a major public health problem in many developing countries in which vaccination coverage is poor, as is the case in the Central African Republic (CAR). At the beginning of the 2000s, a surveillance system was established in the country, and samples from suspected cases are regularly tested in the laboratory for serological confirmation. Since 2007, when case-by-case monitoring with standardized laboratory databases and monitoring, was set up, no assessment have been performed. Therfore, 9 years later it seemed appropriate to make a first assessment. The aim of the study reported here was to describe the epidemiology of measles in the CAR on the basis of surveillance and laboratory data.
A descriptive retrospective study was conducted, based on the databases of the measles surveillance programme and of the Institut Pasteur laboratory in Bangui during the period 2007-2015.
During this study period, the surveillance programme notified 3767 cases. Of these, 2795 (75%) were sent for laboratory confirmation, and 24.6% (687/2795) were confirmed serologically. Of the 1797 cases of measles declared during this period by the surveillance programme, 1110 (61.8%) were confirmed clinically or by epidemiological linkage. The majority of confirmed cases (83.7%; 575/687) occurred in children under 10 years, over half of whom (44.2%; 304/687) were aged 1-4 years. Epidemics occurred regularly between 2011 and 2015, with > 10% of laboratory-confirmed cases. The rate of laboratory investigation was < 80% between 2011 and 2013 but nearly 100% in the other years.
Measles remains a common, endemic illness in the CAR. Improved detection will require better measles surveillance, increased vaccination coverage, revision of the investigation forms to include the WHO case definition and training of the health personnel involved in case-finding in the field.
在许多疫苗接种覆盖率低的发展中国家,麻疹仍然是一个主要的公共卫生问题,中非共和国(中非)就是这种情况。在 21 世纪初,该国建立了一个监测系统,定期在实验室对疑似病例的样本进行血清学确认检测。自 2007 年建立了基于标准化实验室数据库和监测的个案监测以来,尚未进行任何评估。因此,9 年后进行首次评估似乎是合适的。本报告所述研究的目的是根据监测和实验室数据描述中非的麻疹流行病学。
对 2007-2015 年期间麻疹监测计划和班吉巴斯德研究所的数据库进行了描述性回顾性研究。
在研究期间,监测计划报告了 3767 例病例。其中,2795 例(75%)送检实验室确认,24.6%(687/2795)经血清学确认。在监测计划报告的这一期间,有 1797 例麻疹病例,其中 1110 例(61.8%)临床确诊或通过流行病学关联确诊。确诊病例中,大多数(83.7%;575/687)发生在 10 岁以下儿童中,其中超过一半(44.2%;304/687)年龄在 1-4 岁之间。2011 年至 2015 年期间,常规发生了几次疫情,实验室确诊病例超过 10%。2011 年至 2013 年期间,实验室调查率<80%,但在其他年份接近 100%。
麻疹仍然是中非的一种常见地方性疾病。提高检测率需要更好的麻疹监测、提高疫苗接种覆盖率、修订调查表格,包括世卫组织病例定义,并培训参与现场病例发现的卫生人员。